Login

Lu-177 PSMA therapy: published outcomes and cost

How published Lu-177 PSMA trial outcomes differ from an individual prognosis, and where to request an itemised cost estimate.

Editorial update: 3 November 2026. The study references below describe published research, not TPPL-specific outcome rates.

What does a treatment response mean?

Response can refer to changes on imaging, PSA, symptoms or the time before disease progression. These measures are not interchangeable. A published study result is not a guarantee for an individual patient.

What VISION studied

VISION was a randomised study in selected patients with PSMA-positive metastatic castration-resistant prostate cancer after specified previous treatment. Adding Lu-177 PSMA-617 to the trial's standard-care approach improved the measured progression and survival outcomes. Its eligibility criteria and comparator matter when discussing whether the findings apply to a different patient.

What affects an individual discussion?

The team reviews the current PSMA PET-CT, previous therapies, symptoms, marrow and organ function, and the treating oncologist's plan. Published averages do not predict how long a particular person will live.

Cost

Request an itemised per-cycle and course estimate for the proposed product and plan. Check imaging, laboratory work, admission and medicines separately. Lu-177 PSMA therapy cost in India is the dedicated cost page.

Questions to discuss with the treating team

Is a trial response rate my personal chance of benefit?

No. The study population, endpoint and previous treatments must be compared with the individual clinical situation.

Does a lower PSA alone establish the full response?

The treating team assesses PSA alongside imaging, symptoms and safety results.

Published references

Medical disclaimer All physicians and researchers profiled on this page hold appointments in the Department of Nuclear Medicine & Molecular Imaging, Sector 44, Gurugram. Theranostic Physicians Private Limited (TPPL) is the clinical practice entity through which they consult and treat patients. Treatment outcomes vary by individual case; clinical decisions are made on the basis of complete medical records, current imaging, and a multidisciplinary review.